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Background: Minimising diagnostic delays in cancer may help improve survival. Ethnic minorities have worse
outcomes in some cancer types when compared to the majority; this may relate in part to differences during the
diagnostic phase. Only a few British studies have specifically explored this relationship, and no synthesis of these
exists. The present study aimed to systematically review evidence on ethnic inequalities in cancer diagnosis,
focussing on patient and primary care intervals of diagnosis.
Methods: Six electronic databases were searched. Included studies were those conducted in the UK or elsewhere
(where access to healthcare is comparable to the NHS) and those that described a time element during diagnosis.
Study quality was evaluated using the Critical Appraisal Skills Programme (CASP) checklist for cohort studies and
synthesis method was narrative.
Results: Seven of 8,520 studies retrieved by our search met the review criteria; six conducted in the UK, and one in
New Zealand. Five (including one covering several sites) focused on breast cancer, one on prostate, and one on
oesophagogastric cancer. The studies employed different methods of ascertainment and definition of ethnic groups
and defined diagnostic delay in a non-standardised way; therefore, narrative synthesis was performed. In breast
cancer, three studies reported longer diagnostic intervals among ethnic minorities and two found no evidence of
differences by ethnicity. There was some evidence of longer diagnostic and referral intervals among ethnic minorities
in oesophagogastric and colorectal cancers, but no evidence of this in prostate, non-Hodgkin’s lymphoma, lung, and
ovarian cancers. None of the studies identified shorter patient or primary care intervals in ethnic minorities.
Conclusions: Existing studies provide insufficient evidence to confirm or refute ethnic inequalities in diagnostic
intervals of cancer. Further studies are necessary to examine common cancer types including those frequently
found in ethnic minorities (in addition to those covered here) and using current definitions of intervals in cancer
diagnosis.
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Minimising delays in cancer diagnosis - particularly, pa-
tient and primary care delays - may help improve cancer
outcomes in the UK, which at the moment lag behind
most other countries in Europe [1,2]. Recent studies
estimate that 5,000 to 10,000 cancer deaths could be
prevented annually in the UK if efforts to expedite diag-
nosis succeed [1,2]. As some ethnic minorities suffer
more illness and report worse experience of the National
Health Services (NHS) [3], it is possible this will extend* Correspondence: tom205@exeter.ac.uk
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reproduction in any medium, provided the orto cancer diagnostics, contributing to the UK’s poor out-
comes. Few UK studies have specifically explored this re-
lationship, with most evidence coming from the US [4].
The findings of these studies may not be generalisable to
the UK, given the differences in the organisation and op-
erations of the US and UK health care systems in
addition to the differences in nature and composition of
ethnic groups.
Access to health care in the UK is universally free at
the point of delivery with an ethos of equity in service
provision. In theory, this should reduce any disparity in
cancer diagnostics. There is, however, a greater inci-
dence of advanced-stage diagnoses of female breastLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Martins et al. BMC Family Practice 2013, 14:197 Page 2 of 8
http://www.biomedcentral.com/1471-2296/14/197cancer and prostate cancers among ethnic minority
groups compared to the majority [5,6], although these
studies did not report an explanation for their findings.
The reason for such disparities in disease stage is un-
clear given that pre-referral consultation rates are mark-
edly higher among ethnic minority groups with cancer
[7]. It is unknown whether this is the case for other
cancer sites, including those found to be more common
in ethnic minority groups - e.g., mouth, liver, stomach,
oesophagogastric and ovarian cancers [8,9].
Aim of review
The present study aimed to gather and critically appraise
existing evidence on inequalities in cancer diagnosis by
ethnic groups in the UK and in countries with a similar
health care system - in terms of costs, availability and
access [10], specifically examining literature reporting
time to diagnosis of the cancer. We used the schema of
intervals in cancer diagnosis described by Olesen and
colleagues, and illustrated in Figure 1 [11].
Methods
Between 23rd February and 6th March 2012, a
systematic search of six electronic databases (EMBASE,
MEDLINE, PsycINFO, Web of Knowledge, CINAHL
and Campbell Collaboration) was performed. Table 1 in-
cludes the list of search terms used. Inclusion criteria
were: studies focused on adult primary cancers; pub-
lished from January 2000 onwards - marking the start
of major reforms in cancer diagnosis in the UK;Figure 1 Milestone and time intervals from symptoms onset to treatminvestigated ethnic differences in the interval between
symptom onset and GP presentation or the interval be-
tween GP presentation and referral or diagnosis. Exclu-
sion criteria were: studies focused on secondary cancers;
cancer incidence and survival; cancer genetics; screening;
prevention; treatment or co-morbidities; studies from
America (other than Canada), Africa and Asia, Middle
East and Eastern Europe. Our final list of countries
largely matches those countries within the International
Cancer Benchmarking Partnership, which seeks to ex-
plain international differences in cancer outcomes [1].
Two reviewers (TM and CS) independently reviewed the
title, abstract and full text articles (where necessary) to
determine studies inclusion eligibility. Studies that ap-
peared to meet the inclusion criteria or where a decision
could not be made based on the title and/or abstract
were selected for full-text review to identify those for
the final analysis.
Given the methodological heterogeneity of the studies,
a quantitative synthesis was not possible, so we per-
formed a narrative synthesis, using the framework of
Rodgers and colleagues [12]. Data from included studies
were extracted, collated and tabulated by a single ex-
tractor (TM). The primary outcome was the interval be-
tween first symptom experience and eventual diagnosis,
subdivided where possible into patient delay and primary
care delay [13], with the main explanatory variable being
ethnicity. The only subgroup analysis planned was by
cancer site; however, the heterogeneity of the studies
precluded formal meta-analysis, so we performed ourent.
Table 1 Review search terms
Population Exposure Comparison Outcome
Terms relating to cancer : Cancer,
Neoplasm, Malignant Neoplasm, tumour,
Malignant tumour, Astrocytoma,
Adenocarcinoma, Glioma, Mesothelioma,
Medulloblastoma, Myeloma, Melanoma,
Neuroblastoma, Sarcoma, Nonmelanoma,
Osteosarcoma, Teratoma, Seminoma,
Hodgkin, leuk?emia, Lymphoma,
Retinoblastoma
Terms defining ethnic minorities in the
UK: Ethnic* Race* Cultural groups, white
Irish, other whites, African British, Black*
Black Caribbean, British Caribbean,
Asian*, Indian, British, Indian, Pakistani,
British Pakistani, Bangladeshi, British,
Bangladeshi, Chinese, Mixed race
Ethnic majority in
the UK: Ethnic*
Race* Cultural
groups, White
British
Terms relating to intervals of cancer
diagnosis: Duration of symptom; Interval
of symptoms; Time; Delay; Late; Postpone;
and Wait to Symptom, Presentation,
Attendance, Consultation, Appointment,
Diagnosis, Detection, Treatment,
Intervention, Referral. Other terms; Gate
keeping, primary care
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diagnostic intervals studied.
Quality assessment
This used the Critical Appraisal Skills Programme
(CASP) checklist for cohort studies, interpreted to fit
our study topic (see rows 1 and 2 in Table 2 for details).
Each retrieved article was independently appraised by
two reviewers (TM and OU) and was classified as either
“satisfactory”, “medium” or “high” quality paper depend-
ing on the extent to which the checklist items were met,
and also on the level of concerns raised about their
methodology in general. For instance, a concern was
raised where authors classified ethnic groups differently
to the contemporary ethnic classifications in their
population.
Results
Study characteristics
In total, 8,520 articles were identified from the search strat-
egy. After screening the titles and abstracts, and removing
the duplicates, 8,489 irrelevant articles were excluded. The
remaining 31 articles were then retrieved for full text re-
view, and seven met the inclusion criteria and were in-
cluded in the analysis (see flow chart in Figure 2).
Characteristics of the selected studies are shown in
Table 3 with results of the quality assessment in Table 2.
All seven studies were observational, with retrospective
cohort designs, using hospital records, cancer registry
records, survey questionnaires and in-depth interviews.
Six were carried out in the UK, and one in New Zealand.
Five studies [14-18] investigated ethnic differences in
breast cancer diagnosis while the remaining two focused
on prostate [20] and oesophagogastric cancer [19] re-
spectively. Neal and Allgar studied several other cancer
sites in addition to breast: lung, prostate, colorectal non-
Hodgkin’s lymphoma (NHL) and ovarian [18].
Five studies [14-17,20] investigated ethnic differences
in patient delay, that is, delay occurring in the interval
between first symptom and first GP presentation (see
Figure 1). Two of these [16,17] also examined ethnic dif-
ferences in delay following the first GP presentation, but
their definitions of these time periods differed. Nosarti et al.defined delay occurring in the interval between the first GP
presentation and first specialist visit as system delay [17].
Velikova et al. defined the interval between first GP referral
and the first hospital visit as provider’s delay [16]. Neither
of these correspond with current definitions [13]. The
remaining two studies took slightly different approaches
in their definition of delay intervals. Sadler and colleagues
used patients’ referral routes to the hospital as surrogate
measures of primary care delay [19]. They considered
two-week waits (2WW) or ‘Direct Access Oesophago-
gastro-duodenoscopy’ (OGD) as optimal routes to diagnosis,
while waiting for routine appointments and acute admission
were both considered sub-optimal. In addition, they re-
ported ethnic differences in total diagnostic interval, which
is the interval from first symptom to diagnosis. Similarly,
Neal and Allgar reported the same interval, naming it
pre-hospital delay [18]. For the rest of this paper, we
have renamed these ‘the diagnostic interval’. They also
reported ethnic differences in referral delay, which
they defined as the waiting time from first GP visit to
first hospital appointment.
Assessment of study quality
Overall, none of our seven studies had fewer than two con-
cerns and none could be classified as “high quality” due to
the systematic flaws in their methodology - as highlighted
by the CASP assessment shown in Table 2. Only one study
[18] had relatively low risk of bias, and was classified as
“medium quality”. It had a large sample size, investigated
several cancer sites, and classified ethnic groups in a way
that was applicable to their target population. However,
they only reported ethnic differences in pre-hospital delay,
which includes factors relating to the patient, primary and
secondary care and health care system making it difficult
to ascertain where differences have arisen from. The
remaining six studies had a greater overall risk of bias and
were evaluated as “satisfactory”.
Ethnic differences in delay intervals by cancer sites
Breast
Of the five studies that investigated ethnic differences in
breast cancer diagnosis, two [16,18] found evidence of lon-
ger intervals in ethnic minority groups compared to the
Table 2 Quality of studies
CASP question Was the cohort
representative of a
defined population?
Was
everybody
included
Was the exposure
accurately measured
to minimize bias?
Was the outcome
precisely measured
to minimize bias?
Have the authors identified
and adjusted for all key
confounding factors?
How precise are
the results?
Overall
quality
Adapted
question
Unchanged Were all eligible
cancer patients
studied?
Was ethnicity
defined according to
contemporary groupings?
Was diagnostic intervals
measured to Olsen and
colleagues framework?
Unchanged. Key confounders include:
age, gender, SES, co-morbidity,
healthcare system, family history of
cancer and tumour growth rates
Have they presented estimates
of association along with the
confidence intervals? Are the
confidence intervals narrow?
Unchanged
Rajan et al.
(2011) [14]
Met Unmet Partially met Met Unmet Unmet Sat
Meechan et al.
(2002) [15]
Met Partially met Met Met Unmet Unmet Sat
Velikova et al.,
(2004) [16]
Met Partially met Unmet Partially met Partially met Partially met Sat
Nosarti et al.
(2000) [17]
Met Met Met Partially met Partially met Unmet Sat
Neal and Allgar
(2005) [18]
Met Met Met Partially met Partially met Partially met Med
Sadler et al.
(2009) [19]
Met Met Met Partially met Unmet Unmet Sat
Metcalfe et al.
(2008) [20]
Met Partially met Partially met Met Partially met Met Sat
Note: Sat satisfactory; Med medium quality paper.
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ity women of Asian and black origin were more likely to ex-
perience longer diagnostic intervals, even after adjustment
for marital status, gender, age and socioeconomic status
(SES) (P < 0.001) [18]. Similarly, Velikova et al. found longer
patient delay in Asian women compared to non-Asian
(median of 61 days vs. median of 31 days, P = 0.005) even
after adjustment for SES, age and health care settings [16].
Another study, Rajan et al., found that nearly half (45%) of
the Asian women in their West Yorkshire (UK) cohort
delayed over two months before presenting with breast
symptoms [14]. They labelled this as ‘delay’ but without
providing data for non-Asians. The remaining two studies
[15,17] found no difference by ethnicity.
Oesophagogastric
Sadler and colleagues found evidence that Asians (13%)
were less likely to take the optimal route to diagnosis
(OGD and 2WW) compared to blacks (49%) andFigure 2 Flow chart of study selection process.Caucasians (39%); P = 0.01 [19]. They also found that
Asians (39%) and blacks (45%) were less likely to be di-
agnosed within three months of symptom discovery
compared to Caucasians (63%); P = 0.03).
Colorectal
Neal and Allgar reported longer referral delay among
Asians and Blacks even after adjustment for marital sta-
tus, gender, age and SES (P = 0.02) [18]. No difference by
ethnicity was found in pre-hospital delay.
Other cancer sites
For lung, prostate, NHL, and ovarian cancers no evi-
dence was found of differences in delay interval across
ethnic groups [18,20].
Discussion
Health service provision must be culturally sensitive if
health inequalities are to be reduced and eliminated.
Table 3 Characteristics and findings of reviewed studies
Author Country Title/aim Site Sample size (n)
gender age
Method Ethnic groups Relevant outcome
measures
Results
Exposure Comparison
Rajan et al.
(2011) [14]
UK (West
Yorkshire)
To improve knowledge
about late presentation
and management of
breast cancer among
South Asian women.
Breast n = 1,630
(36 South Asian
women) all
female median
age = 53.5 years
Retrospective:
Breast cancer
waiting list
database and
case notes
South Asian
women; Indians
and Pakistanis
None; throughout
the paper, including
the title, the authors
imply South Asian
women had more
delay
Duration of breast
symptoms prior
to presentation
within primary
care
45% of Asian women delayed
symptoms beyond 8 weeks before
visiting their GP
Meechan et al.
(2002) [15]
New
Zealand
Delay in seeking medical
care for self-detected
breast symptoms in
New Zealand women.
Breast n = 85 all
female mean
age =38 years
Retrospective:
questionnaire
& patient record
Minority New
Zealanders - Maori,
Pacific & Asian/
Indian
European New
Zealanders
Patient delay No difference in patient delay by
ethnicity.
Velikova et al.
(2004) [16]
UK (South
Yorkshire)
To describe the effect of
ethnicity on tumour
stage, treatment, patient
and providers delays in
diagnosis of breast cancer
Breast n = 16,879 all
female mean
age = 49.7 years
in Asians and
62 years in
non-Asians
Retrospective:
Cancer registry
data
South Asian Non-Asian Patients and
providers delays
to diagnosis
After adjusting for, age, SES and
health care settings; patient delay
was longer in Asian than in
non –Asian women (median of
61 days vs. median of 31 days,
P = 0.005)
Nosarti et al.
(2000) [17]
UK To identify factors
associated with delay
in presentation and
assessment of
symptomatic breast
cancer
Breast n = 692 all
female median
age = 49 years
Retrospective:
Interview, GP &
hospital records
African Afro-
Caribbean
and Asian
British and
other white
Patient and
system delay
Ethnicity were non-contributory
to patient delay in breast cancer
Neal and Allgar
(2005) [18]
UK To explore the
relationship between
socio-demographic
factors & delays in the
diagnosis of six cancers
Breast, lung,
colorectal,
prostate
NHL, and
ovarian
n = 65,192
male & female
all age groups
Retrospective:
Analysis of the
National Survey
Data
Blacks - Africans,
Caribbean & others
blacks. South
Asians -Indian,
Pakistani,
Bangladeshi,
others.
Whites Total, pre-hospital,
referral and
secondary care
delay
After adjusting for marital status,
gender, age and SES, Asian and
black had longer pre-hospital
delays for breast cancer in women
(P = 0.001) and longer referral delay
for colorectal cancer (P = 0.02). No
evidence of difference for lung,
prostate, NHL and ovarian.
Sadler et al.
(2009) [19]
UK
(Birmingham)
The effect of ethnicity
on the presentation
and management of
oesophageal and gastric
cancers: A UK perspective
oesophageal
& gastric
n = 244 male &
female median
age = 71 years
Retrospective:
Case-note audit
Asians and Blacks Caucasians Referral routes
and total
diagnostic
interval
Asians and Blacks compared to
Caucasians were less likely to be
diagnosed within 3 months of
symptom discovery (P = 0.03) and
less likely to take the optimal
route to diagnosis (p = 0.01).
Metcalfe et al.
(2008) [20]
UK To examine the pathways
followed by black and
white men to prostate
cancer diagnosis
Prostate n = 1,866
men median
age = 67.9 years
in blacks
73.3 years in
whites
Retrospective:
Questionnaire,
hospital records
and cancer
registry data
Black men White men Delay between
onset of
symptoms and
first GP
presentation.
After adjusting for age and hospital
centre, no significant difference
between white and black men in
patient delay (odds ratio: 0.82;
95% CI: 0.57 to 1.19)
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becomes even more multicultural with considerable in-
creases in ethnic minority population. Few UK studies
have specifically explored ethnic inequalities in cancer
diagnosis, and to the best of our knowledge no synthesis
of evidence exists.
Strengths and limitations
Our rigorous search strategy, and explicit inclusion/ex-
clusion criteria, quality assessment of included studies
and narrative synthesis followed best practice. Our
search identified only a small number of studies, the
bulk of which were (unsurprisingly) conducted in the
UK, given that the UK is one of the most ethnically
diverse countries in Europe. Our decision to omit
American studies (other than Canada) was based on
their very different health care system and ethnic group-
ings; it considerably reduced the number of selected
studies, although this reflected our research question of
whether there are ethnic inequalities in the time to diag-
nosis of cancer within a free health care system. A limi-
tation was that most studies focused on breast cancer,
reducing the scope of the review. Furthermore, any re-
view is only as good as the studies it finds. Our selec-
tions differed considerably in methodology - especially
in the definitions of intervals before diagnosis, which
made quantitative synthesis inappropriate, and compli-
cated the narrative synthesis. Participants’ ethnic groups
were poorly defined in some studies; at times there was
a mismatch between the ethnic groupings used for the
study and contemporary ethnic groupings used in the
whole population from which their sample was drawn
[16,20]. We interpreted the CASP quality instrument for
this review - primarily to fit our study topic: it is unlikely
these minor changes led to more studies ‘failing’ our
quality assessment. Finally, publication bias is possible as
studies showing no association between ethnicity and
cancer diagnostic delays may have failed to be published,
leaving us with disproportionately positive studies.
Comparison with previous studies
Two previous reviews [21,22] have examined delays in
cancer diagnosis, although neither examined ethnicity.
In both (like in the present review), the intervals were
defined in a nonstandard way. This is understandable, as
terminology in this subject was ill-defined before the ad-
vent of the Aarhus statement [13]. This provides more
precise description of milestones along the cancer diag-
nostic pathway, as well as describing preferred research
methodologies. In an assessment of primary care use
prior to cancer diagnosis, Lyratzopoulos and colleagues
found that ethnic minority groups were more likely to
have consulted their GPs three or more times before
hospital referral (odds ratio for Asian vs. white 1 · 73,1 · 45 to 2 · 08; p < 0 · 0001; odds ratio for black vs. white
1 · 83, 1 · 51 to 2 · 23; p < 0 · 0001. This study did not report
durations or intervals to diagnosis, so would not have met
our inclusion criteria, though its results are consistent
with our findings.
Review findings
We found limited, methodologically-weak evidence for
ethnic inequalities in cancer diagnosis, though largely
for breast cancer. Conversely, the review found no evi-
dence to suggest that ethnic minority groups were doing
better at any stage of cancer diagnostic pathway. For
breast cancer, three (of five studies) found longer patient
and pre-hospital delays in ethnic minority women com-
pared to their white counterparts; while the remaining
two reported no difference. The latter two studies sam-
pled participants from a relatively small number of
women referred to a specialist clinic for further investi-
gation. It is well-recognised that cancer patients may
take alternative routes to diagnosis, such as routine spe-
cialist clinics or emergency admission; these will have
been omitted from the two studies based in specialist
clinics [23,24]. Furthermore, both studies were based
on interviewing patients about their delay experiences
whilst in the specialist waiting room. Therefore, their
findings may have been influenced by selection and re-
call biases. In contrast, the three studies finding differ-
ences in diagnostic intervals across ethnic groups
recruited participants with definite diagnosis of breast
cancer, and then surveyed or examined their medical
record for important dates of presentation and referral.
Conclusion
Redressing inequalities in health (including those relat-
ing to ethnic diversity) is central to most reforms and
strategies on health and social services in the UK. How-
ever, as the government progresses with the implemen-
tation of its austerity measures (with considerable cuts
to health care expenditure) there are concerns that
providers may prioritise differently. Potentially, some
services including those intended to meet the specific
health care needs of ethnic minority communities may
be compromised - e.g., tailored services for language and
communication needs, and the need for gender-specific
providers. To ensure that policies are tailored to need,
sufficient evidence is crucial. If existing evidence sug-
gests ethnic variations in diagnostic delay, then policies
aimed at promoting early diagnosis should also target
the affected groups.
This review found some evidence for ethnic differ-
ences in cancer diagnosis with ethnic minorities taking
longer to diagnosis. The evidence was largely in breast
cancer patients. However, these findings are from
methodologically heterogeneous studies, with different
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prone to bias. Future studies will need to examine the
subject using a clearly defined and representative sample
of ethnic minority groups, incorporate cancer types that
are more common in ethnic minority groups and em-
ploy the definitions of cancer diagnostics in the Aarhus
statement. This should be possible with the advent of
large linked datasets containing routine healthcare data
(e.g., the Diagnostic Imaging Dataset which incorporates
ethnicity as a variable).
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